Delivery Order SPE2DB20D7059-SPE2DB23FPXW4
Award Date 2/17/23
Potential Completion Date 2/21/23
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,829,247 Typhim VI 25 MCG/0.5 ML Vial 10ML vaccines. The $6,156.31 firm fixed price contract has a period of performance through September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and other federal agencies to provide a wide range...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,675 units of the Typhim VI 25 mcg/0.5 mL vaccine vial in 10 mL sizes. The contract, valued at $74,946.36, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $16,372.29 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 25 mcg Typhoid vaccine doses, with a completion date of March 7, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is not designated as a set-aside. The contract is part of...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,452.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 25 mcg/0.5 ml vials of the TYPHIM VI vaccine. This delivery order contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,044.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,916.36 firm fixed price delivery order is for the supply of 10 mL vials of the TYPHIM VI 25 MCG/0.5 ML vaccine. No set-aside designation was used. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,545,937 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a total potential value of $5,276.45 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver this...
- The Defense Logistics Agency awarded a $5,700.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 13, 2025, with completion scheduled for November 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,325,039 units of the Typhim VI 25 mcg/0.5 mL vaccine. The firm-fixed-price delivery order contract, valued at $1,957.58, runs through November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,726.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 4,563,415,015 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a period of performance through January 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...